ARTICLE | Company News
AstraZeneca submits Zactima applications
July 31, 2009 1:13 AM UTC
AstraZeneca plc (LSE:AZN; NYSE:AZN) said on Thursday that in June it submitted an NDA to FDA and an MAA to EMEA for Zactima vandetanib 100 mg as second-line treatment for advanced non-small cell lung ...